310 related articles for article (PubMed ID: 22973309)
1. Glioma revisited: from neurogenesis and cancer stem cells to the epigenetic regulation of the niche.
de Almeida Sassi F; Lunardi Brunetto A; Schwartsmann G; Roesler R; Abujamra AL
J Oncol; 2012; 2012():537861. PubMed ID: 22973309
[TBL] [Abstract][Full Text] [Related]
2. Glioma stem cell research for the development of immunotherapy.
Ji J; Black KL; Yu JS
Neurosurg Clin N Am; 2010 Jan; 21(1):159-66. PubMed ID: 19944974
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma Multiforme and Adult Neurogenesis in the Ventricular-Subventricular Zone: A Review.
Capdevila C; Rodríguez Vázquez L; Martí J
J Cell Physiol; 2017 Jul; 232(7):1596-1601. PubMed ID: 27458813
[TBL] [Abstract][Full Text] [Related]
4. Role and mechanism of neural stem cells of the subventricular zone in glioblastoma.
Zhang GL; Wang CF; Qian C; Ji YX; Wang YZ
World J Stem Cells; 2021 Jul; 13(7):877-893. PubMed ID: 34367482
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.
Thirant C; Bessette B; Varlet P; Puget S; Cadusseau J; Tavares Sdos R; Studler JM; Silvestre DC; Susini A; Villa C; Miquel C; Bogeas A; Surena AL; Dias-Morais A; Léonard N; Pflumio F; Bièche I; Boussin FD; Sainte-Rose C; Grill J; Daumas-Duport C; Chneiweiss H; Junier MP
PLoS One; 2011 Jan; 6(1):e16375. PubMed ID: 21297991
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
7. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
8. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.
Bou-Gharios J; Assi S; Bahmad HF; Kharroubi H; Araji T; Chalhoub RM; Ballout F; Harati H; Fares Y; Abou-Kheir W
Pharmacol Rep; 2021 Feb; 73(1):227-239. PubMed ID: 33140310
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance.
Pang LY; Saunders L; Argyle DJ
Oncotarget; 2017 Sep; 8(42):72494-72512. PubMed ID: 29069805
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
11. A narrative review of research progress on drug therapies for glioblastoma multiforme.
Zheng X; Tang Q; Ren L; Liu J; Li W; Fu W; Wang J; Du G
Ann Transl Med; 2021 Jun; 9(11):943. PubMed ID: 34350258
[TBL] [Abstract][Full Text] [Related]
12. The landscape of the mesenchymal signature in brain tumours.
Behnan J; Finocchiaro G; Hanna G
Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
[TBL] [Abstract][Full Text] [Related]
13. Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells.
Reddy RG; Bhat UA; Chakravarty S; Kumar A
Cancer Chemother Pharmacol; 2020 Aug; 86(2):165-179. PubMed ID: 32638092
[TBL] [Abstract][Full Text] [Related]
14. Beyond Genetics in Glioma Pathways: The Ever-Increasing Crosstalk between Epigenomic and Genomic Events.
Martínez R
J Signal Transduct; 2012; 2012():519807. PubMed ID: 22778947
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
16. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.
Garcia JL; Perez-Caro M; Gomez-Moreta JA; Gonzalez F; Ortiz J; Blanco O; Sancho M; Hernandez-Rivas JM; Gonzalez-Sarmiento R; Sanchez-Martin M
BMC Cancer; 2010 Aug; 10():454. PubMed ID: 20735813
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of malignant gliomas.
Belda-Iniesta C; de Castro Carpeño J; Casado Sáenz E; Cejas Guerrero P; Perona R; González Barón M
Clin Transl Oncol; 2006 Sep; 8(9):635-41. PubMed ID: 17005465
[TBL] [Abstract][Full Text] [Related]
19. [Progress in the study of brain tumor stem cells as treatment targets].
Hide T; Kuratsu J
Brain Nerve; 2009 Jul; 61(7):781-9. PubMed ID: 19618855
[TBL] [Abstract][Full Text] [Related]
20. The role of cancer stem cells (CD133(+)) in malignant gliomas.
Cho DY; Lin SZ; Yang WK; Hsu DM; Lin HL; Lee HC; Lee WY; Chiu SC
Cell Transplant; 2011; 20(1):121-5. PubMed ID: 20887676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]